List Drug Candidate

BioNeex Interviews

BioNeex Interviews are part of the BioNeex vision. They provide a social media exposure to early stage biotech companies and their R&D pipelines in order to attract the right licensing and co-development partners. During the interview the interviewee, typically a biotech CEO, addresses the company’s message to potential partners, investors and other external stakeholders.
BioNeex Interview with AP, Oncology Lead at CHBC, Dr. James T. Lee discussing Cancer Progress

Cello Health BioConsulting (CHBC), previously Defined Health, is hosting the 30th annual Cancer Progress conference, the prem

Apr 23, 2019

Gene Therapy
BioNeex Interview with Associate Principal at CHBC, Dr. Joel S. Sandler discussing Cancer Progress

Cello Health BioConsulting (CHBC), previously Defined Health, is hosting the 30th annual Cancer Progress conference, the prem

Apr 23, 2019

Gene Therapy
BioNeex Interview with CEO of StemTek Therapeutics Dr Angel Garcia Martin

About BioNeex BioNeex is an online, peer-to-peer platform for R&D-stage licensing and collaborative partnerships in the b

Apr 24, 2019

Gene Therapy
BioNeex Interview with Executive Chairman & Founder of CHBC, Ed Saltzman discussing Cancer Progress

Cello Health BioConsulting (CHBC), previously Defined Health, is hosting the 30th annual Cancer Progress conference, the prem

Apr 23, 2019

Gene Therapy
BioNeex Interview with Jeff Bockman, PhD - Trends and Future Insights in the Immuno-Oncology Space

The interview provides insights into the dynamic space of Immuno-Oncology. To learn more, join BioNeex Webinar #2, in coopera

Oct 17, 2018

Gene Therapy
BioNeex Interview with EVP, Head of Oncology at CHBC, Dr. Jeffrey Bockman discussing Cancer Progress

Cello Health BioConsulting (CHBC), previously Defined Health, is hosting the 30th annual Cancer Progress conference, the prem

Apr 23, 2019

Gene Therapy
BioNeex Expert Interview with Dr. Hitesh Mistry from Physiomics - Cancer Drug Licensing

By watching this expert interview you will learn as a development-stage biopharma company what is the best way to present you

Mar 12, 2019

Gene Therapy